These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1345796)

  • 1. The effect of sulfasalazine on bovine endothelial cell proliferation and cell cycle phase distribution. Comparison with olsalazine, 5-aminosalicylic acid, and sulfapyridine.
    Sharon P; Drab EA; Linder JS; Weidman SW; Sabesin SM; Rubin DB
    J Lab Clin Med; 1992 Jan; 119(1):99-107. PubMed ID: 1345796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actions of sulfasalazine and 5-aminosalicylic acid as reactive oxygen scavengers in the suppression of bile acid-induced increases in colonic epithelial cell loss and proliferative activity.
    Craven PA; Pfanstiel J; Saito R; DeRubertis FR
    Gastroenterology; 1987 Jun; 92(6):1998-2008. PubMed ID: 2883067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of neutrophil degranulation and superoxide production by sulfasalazine. Comparison with 5-aminosalicylic acid, sulfapyridine and olsalazine.
    Neal TM; Winterbourn CC; Vissers MC
    Biochem Pharmacol; 1987 Sep; 36(17):2765-8. PubMed ID: 2888463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the beneficial effect of sulfasalazine due to inhibition of synovial neovascularization?
    Madhok R; Wijelath E; Smith J; Watson J; Sturrock RD; Capell HA
    J Rheumatol; 1991 Feb; 18(2):199-202. PubMed ID: 1708829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of antibody secretion by 5-aminosalicylic acid.
    MacDermott RP; Schloemann SR; Bertovich MJ; Nash GS; Peters M; Stenson WF
    Gastroenterology; 1989 Feb; 96(2 Pt 1):442-8. PubMed ID: 2562949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis.
    Volin MV; Harlow LA; Woods JM; Campbell PL; Amin MA; Tokuhira M; Koch AE
    Arthritis Rheum; 1999 Sep; 42(9):1927-35. PubMed ID: 10513809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.
    Stevens C; Lipman M; Fabry S; Moscovitch-Lopatin M; Almawi W; Keresztes S; Peppercorn MA; Strom TB
    J Pharmacol Exp Ther; 1995 Jan; 272(1):399-406. PubMed ID: 7815356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro immunomodulatory effects of sulfasalazine and its metabolites.
    Comer SS; Jasin HE
    J Rheumatol; 1988 Apr; 15(4):580-6. PubMed ID: 2899646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfasalazine treatment and lymphocyte function in patients with rheumatoid arthritis.
    Symmons DP; Salmon M; Farr M; Bacon PA
    J Rheumatol; 1988 Apr; 15(4):575-9. PubMed ID: 2899645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of sulfasalazine and its metabolites on prostaglandin and leukotriene liberation from human synovial tissue].
    Wittenberg HR; Kleemeyer K; Peskar BM; Peskar BA
    Wien Klin Wochenschr; 1991; 103(2):34-9. PubMed ID: 1673814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of diarrhoea producing gram negative enteric bacteria to sulfasalazine, 5-aminosalicylic acid, sulfapyridine and four quinolones. Brief report.
    Andreasen JJ; Andersen LP; Hartzen SH
    APMIS; 1988 Jun; 96(6):568-70. PubMed ID: 2899438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifolate actions of sulfasalazine on intact lymphocytes.
    Baum CL; Selhub J; Rosenberg IH
    J Lab Clin Med; 1981 Jun; 97(6):779-84. PubMed ID: 6112249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfasalazine and its metabolites attenuate respiratory burst of leukocytes--a possible mechanism of anti-inflammatory effects.
    Suematsu M; Suzuki M; Miura S; Nagata H; Oshio C; Asakura H; Watanabe M; Tsuchiya M
    J Clin Lab Immunol; 1987 May; 23(1):31-3. PubMed ID: 2886669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
    Bird HA
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():16-9. PubMed ID: 8535642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of sulfasalazine, 5-aminosalicylic acid and sulfapyridine on prostanoid synthesis and metabolism in rabbit colonic mucosa.
    Kolassa N; Becker R; Wiener H
    Prostaglandins; 1985 Jan; 29(1):133-42. PubMed ID: 2858116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cytotoxicity by sulfasalazine. II. Sulfasalazine and sulfapyridine inhibit different stages of the NK and NKCF lytic processes.
    Shanahan F; Niederlehner A; MacDermott RP; Stenson WF; Kane MG; Targan S
    Immunopharmacology; 1986 Apr; 11(2):111-8. PubMed ID: 2872187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells.
    Funk SE; Sage EH
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2648-52. PubMed ID: 2011576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfasalazine and 5-aminosalicylic acid inhibit contractile leukotriene formation.
    Nielsen ST; Beninati L; Buonato CB
    Scand J Gastroenterol; 1988 Apr; 23(3):272-6. PubMed ID: 2898806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of sulphasalazine, 5-aminosalicylic acid and sulphapyridine on the humoral response to antigen in vivo.
    Sheldon P; Pell P
    Adv Exp Med Biol; 1995; 371B():905-8. PubMed ID: 7502923
    [No Abstract]   [Full Text] [Related]  

  • 20. Azodisalicylate (azodisal sodium) causes intestinal secretion. Comparative study of the effect of azodisalicylate, sulfasalazine, 5-aminosalicylic acid and sulfapyridine on the water and electrolyte transfer and the morphology of the rat ileum and colon in vivo.
    Goerg KJ; Wanitschke R; Gabbert H; Breiling J; Franke M; Meyer zum Büschenfelde KH
    Digestion; 1987; 37(2):79-87. PubMed ID: 2887473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.